Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Patients with long-term chronic diseases are likely to respond more slowly to the addition of GLP-1 therapy
A health care provider must document that the patient met the appropriate requirements when GLP-1 therapy began
Always review your full medical history with your provider
Studies have shown people to have significant reductions in weight and waist circumference after taking these medications
Hasenour, C
While those medications target the GLP-1 (glucagon-like peptide-1) receptor, Tirzepatide is classified as a dual agonist, meaning it acts on both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor
US$ 28.78
US$ 28.46
US$ 25.61
US$ 26.41
US$ 21.58
